A San Diego startup has joined the stampede of medical diagnostic startups that are offering to help consumers decode their own personal genome to determine their risk for disease. Pathway Genomics, which announced its debut yesterday, joins Complete Genomics and 23andMe, which are both based in Mountain View, CA, Navigenics of Foster City, CA, and deCODE Genetics of Reykjavik, Iceland. Pathway says it can test consumers for their genetic risk to more than 90 health conditions for $250. Consumers also can order an ancestry test for $200, or both services for $350.
By posting a comment, you agree to our terms and conditions.